Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott A Fulton

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Antimicrobial Agents and Chemotherapy|May 11, 2023
Investigating and Treating a Corneal Ulcer Due to Extensively Drug-Resistant Pseudomonas aeruginosaMorgan K Morelli, Amy Kloosterboer, Scott A Fulton, et al.
Journal of Global Antimicrobial Resistance|October 11, 2019
A two-part phase 1 study to establish and compare the safety and local tolerability of two nasal formulations of XF-73 for decolonisation of Staphylococcus aureus: A previously investigated 0.5mg/g viscosified gel formulation versus a modified formulationGeorge A Yendewa, J McLeod Griffiss, Michael R Jacobs, et al.
Antibiotics (Basel, Switzerland)|April 23, 2022
Dosing Colistimethate Every 8 h Results in Higher Plasma Concentrations of Active Colistin Than Every 12-Hourly Dosing without Increase in Nephrotoxicity: A Phase 1 Pharmacokinetics Trial in Healthy Adult VolunteersGeorge A Yendewa, John McLeod Griffiss, Wesley A Gray, et al.
Immunology|September 29, 2006
Mycobacteria lacking the RD1 region do not induce necrosis in the lungs of mice lacking interferon-gammaAna Paula Junqueira-Kipnis, Randall J Basaraba, Veronica Gruppo, et al.
European Journal of Immunology|February 6, 2014
TLR2 engagement on CD4(+) T cells enhances effector functions and protective responses to Mycobacterium tuberculosisScott M Reba, Qing Li, Sophia Onwuzulike, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Antimicrobial Agents and Chemotherapy|May 11, 2023
Investigating and Treating a Corneal Ulcer Due to Extensively Drug-Resistant Pseudomonas aeruginosaMorgan K Morelli, Amy Kloosterboer, Scott A Fulton, et al.
Journal of Global Antimicrobial Resistance|October 11, 2019
A two-part phase 1 study to establish and compare the safety and local tolerability of two nasal formulations of XF-73 for decolonisation of Staphylococcus aureus: A previously investigated 0.5mg/g viscosified gel formulation versus a modified formulationGeorge A Yendewa, J McLeod Griffiss, Michael R Jacobs, et al.
Antibiotics (Basel, Switzerland)|April 23, 2022
Dosing Colistimethate Every 8 h Results in Higher Plasma Concentrations of Active Colistin Than Every 12-Hourly Dosing without Increase in Nephrotoxicity: A Phase 1 Pharmacokinetics Trial in Healthy Adult VolunteersGeorge A Yendewa, John McLeod Griffiss, Wesley A Gray, et al.
Immunology|September 29, 2006
Mycobacteria lacking the RD1 region do not induce necrosis in the lungs of mice lacking interferon-gammaAna Paula Junqueira-Kipnis, Randall J Basaraba, Veronica Gruppo, et al.
European Journal of Immunology|February 6, 2014
TLR2 engagement on CD4(+) T cells enhances effector functions and protective responses to Mycobacterium tuberculosisScott M Reba, Qing Li, Sophia Onwuzulike, et al.
Pageof 2